Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021
NCT07302607
·
clinicaltrials.gov ↗
RECRUITING
Status
221
Enrollment
OTHER
Sponsor class
Conditions
Stage III Melanoma
Sponsor
University Hospital, Strasbourg, France